In cell proliferation assays, we showed that the TSC2 siRNA partially restored NSCLC cell growth in the presence of rosiglitazone, although knockdown of TSC2 alone had no effect on NSCLC cell proliferation. The gene discussed is TSC2; the disease is non-small cell lung carcinoma.